Jaguar Health's Crofelemer Shows Benefit for Intestinal Failure (IF) in Third Rare Congenital Enteropathy Disorder

Mutation of the GUCY2C gene is the third IF-related congenital enteropathy, in addition to microvillus inclusion disease and short bowel syndrome , for which crofelemer has demonstrated benefit in